From the Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, South Korea (Kang, C. Kim, S.J. Kim); the Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea (D.Y. Kim); and the Yonsei Phil Neuropsychiatric Clinic, Seoul, South Korea (Lee).
J Psychiatry Neurosci. 2019 Jul 1;44(4):261-268. doi: 10.1503/jpn.180064.
Deficits in cortical inhibitory processes have been suggested as underlying pathophysiological mechanisms of obsessive–compulsive disorder (OCD). We examined whether patients with OCD have altered cortical excitability using paired-pulse transcranial magnetic stimulation (TMS). We also tested associations between TMS indices and OCD-related characteristics, including age of onset and response inhibition in the go/no-go paradigm, to examine whether altered cortical excitability contributes to symptom formation and behavioural inhibition deficit in patients with OCD.
We assessed motor cortex excitability using paired-pulse TMS in 51 patients with OCD and 39 age-matched healthy controls. We also assessed clinical symptoms and response inhibition in the go/nogo task. All patients were undergoing treatment with serotonin reuptake inhibitors. We performed repeated-measures multivariate analysis of covariance to compare TMS indices between patients with OCD and controls.
Compared to controls, patients with OCD showed a shorter cortical silent period and decreased intracortical facilitation. However, we found no significant difference between groups for resting motor threshold or short-interval intracortical inhibition. In the OCD group, the shortened cortical silent period was associated with a prompt reaction time in the go/no-go task and with early onset of OCD.
We could not exclude the influence of medications on motor cortex excitability.
These findings suggest abnormal cortical excitability in patients with OCD. The associations between cortical silent period and response inhibition and age of onset further indicate that altered cortical excitability may play an important role in the development of OCD.
皮质抑制过程的缺陷被认为是强迫症(OCD)的潜在病理生理机制。我们使用成对经颅磁刺激(TMS)检查 OCD 患者的皮质兴奋性是否改变。我们还测试了 TMS 指数与 OCD 相关特征之间的关联,包括发病年龄和 Go/No-Go 范式中的反应抑制,以检查皮质兴奋性改变是否导致 OCD 患者的症状形成和行为抑制缺陷。
我们使用成对 TMS 评估了 51 名 OCD 患者和 39 名年龄匹配的健康对照者的运动皮质兴奋性。我们还评估了 Go/No-Go 任务中的临床症状和反应抑制。所有患者均接受选择性 5-羟色胺再摄取抑制剂治疗。我们进行了重复测量多元协方差分析,以比较 OCD 患者和对照组之间的 TMS 指数。
与对照组相比,OCD 患者的皮质静息期较短,皮质内易化减少。然而,我们未发现两组间的静息运动阈值或短间隔皮质内抑制有显著差异。在 OCD 组中,皮质静息期缩短与 Go/No-Go 任务中的快速反应时间和 OCD 的早期发病有关。
我们不能排除药物对运动皮质兴奋性的影响。
这些发现表明 OCD 患者的皮质兴奋性异常。皮质静息期与反应抑制和发病年龄之间的关联进一步表明,皮质兴奋性改变可能在 OCD 的发展中起重要作用。